BFO
MDT icon

Boston Family Office’s Medtronic MDT Stock Holding History

Boston Family Office’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.36M Sell
27,251
-182
-0.7% -$17.4K 0.16% 111
2025
Q4 		$2.63M Sell
27,433
-1,038
-4% -$101K 0.17% 106
2025
Q3 		$2.71M Buy
28,471
+159
+0.6% +$14.6K 0.17% 103
2025
Q2 		$2.47M Buy
28,312
+1,917
+7% +$163K 0.16% 103
2025
Q1 		$2.37M Sell
26,395
-910
-3% -$81.4K 0.17% 104
2024
Q4 		$2.18M Buy
27,305
+413
+2% +$35.8K 0.15% 107
2024
Q3 		$2.42M Hold
26,892
– – 0.16% 103
2024
Q2 		$2.12M Sell
26,892
-1,940
-7% -$159K 0.15% 107
2024
Q1 		$2.51M Buy
28,832
+313
+1% +$26.7K 0.18% 96
2023
Q4 		$2.35M Buy
28,519
+4,516
+19% +$344K 0.18% 100
2023
Q3 		$1.88M Buy
24,003
+4,203
+21% +$352K 0.15% 113
2023
Q2 		$1.74M Buy
19,800
+2,722
+16% +$234K 0.13% 118
2023
Q1 		$1.38M Buy
17,078
+850
+5% +$69.3K 0.11% 130
2022
Q4 		$1.26M Buy
16,228
+1,938
+14% +$157K 0.1% 138
2022
Q3 		$1.15M Buy
14,290
+1,276
+10% +$115K 0.1% 139
2022
Q2 		$1.17M Buy
13,014
+1,620
+14% +$164K 0.1% 138
2022
Q1 		$1.26M Buy
11,394
+736
+7% +$77.8K 0.09% 139
2021
Q4 		$1.1M Buy
10,658
+258
+2% +$29.9K 0.07% 155
2021
Q3 		$1.3M Buy
10,400
+100
+1% +$12.9K 0.09% 144
2021
Q2 		$1.28M Buy
10,300
+510
+5% +$64K 0.09% 150
2021
Q1 		$1.09M Buy
9,790
+554
+6% +$64.9K 0.08% 155
2020
Q4 		$1.08M Buy
9,236
+865
+10% +$95.2K 0.08% 155
2020
Q3 		$870K Hold
8,371
– – 0.08% 155
2020
Q2 		$768K Sell
8,371
-1,290
-13% -$124K 0.07% 156
2020
Q1 		$871K Buy
9,661
+494
+5% +$52.6K 0.1% 140
2019
Q4 		$1.04M Sell
9,167
-20
-0.2% -$2.19K 0.1% 141
2019
Q3 		$998K Buy
9,187
+74
+0.8% +$7.72K 0.1% 141
2019
Q2 		$888K Buy
9,113
+1,303
+17% +$119K 0.09% 151
2019
Q1 		$711K Sell
7,810
-26
-0.3% -$2.33K 0.08% 161
2018
Q4 		$713K Sell
7,836
-862
-10% -$80.6K 0.09% 160
2018
Q3 		$856K Sell
8,698
-107
-1% -$9.89K 0.09% 157
2018
Q2 		$754K Sell
8,805
-673
-7% -$56.2K 0.09% 163
2018
Q1 		$760K Buy
9,478
+219
+2% +$18.1K 0.09% 164
2017
Q4 		$748K Buy
9,259
+462
+5% +$37K 0.08% 169
2017
Q3 		$684K Buy
8,797
+158
+2% +$13.1K 0.08% 174
2017
Q2 		$767K Buy
8,639
+204
+2% +$17.2K 0.09% 161
2017
Q1 		$680K Sell
8,435
-868
-9% -$67.8K 0.08% 169
2016
Q4 		$663K Sell
9,303
-23
-0.2% -$1.81K 0.09% 172
2016
Q3 		$806K Sell
9,326
-1,429
-13% -$125K 0.1% 160
2016
Q2 		$933K Sell
10,755
-511
-5% -$41.3K 0.12% 149
2016
Q1 		$845K Buy
11,266
+4,985
+79% +$375K 0.11% 152
2015
Q4 		$483K Sell
6,281
-664
-10% -$50K 0.07% 180
2015
Q3 		$465K Sell
6,945
-1,171
-14% -$86.2K 0.06% 185
2015
Q2 		$601K Sell
8,116
-11,597
-59% -$886K 0.08% 186
2015
Q1 		$1.54M Buy
+19,713
New +$1.49M 0.19% 117

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boston Family Office's MDT Position: Q1 2026 in Review

Boston Family Office reduced its Medtronic (MDT) stake by 0.66% in Q1 2026, selling an estimated $17.4K and leaving 27,251 shares worth $2.36M. The position accounts for 0.16% of the portfolio, ranked #111.

Boston Family Office first reported a position in MDT in Q1 2015 and has held it in 45 quarters since. The position peaked at $2.71M in Q3 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Boston Family Office held 27,251 shares of Medtronic worth $2.36M as of Q1 2026.
  • Boston Family Office sold 182 Medtronic shares in Q1 2026, an estimated $17.4K.
  • Medtronic made up 0.16% of Boston Family Office's portfolio in Q1 2026, its #111 holding.
  • Boston Family Office first reported a position in Medtronic in Q1 2015 and has held it in 45 quarters since.
  • Boston Family Office's Medtronic position peaked at $2.71M in Q3 2025.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Boston Family Office's 13F filing for Q1 2026, filed 13 May 2026.